We want to make sure everyone has access to the treatment they need. That’s why we fund research into all stages of MS.

Mollie McKeon is a PhD researcher at the University of Cambridge, where she researches the genetics of MS progression. Mollie’s mum Ceridwen Roberts lives with secondary progressive MS.

This year marked our anniversary. Find out what happened in 2023 in the world of MS research.

At ECTRIMS 2023, the world's largest MS research conference, researchers shared ideas about the microbiome and how it could be involved in MS.

PhD student Hannah Morris-Bankole and psychologist Dr Laura Allen both live with relapsing remitting MS. They met for the first time and discussed how different therapy styles could be beneficial for people with MS at different times.

From Epstein Barr Virus to myelin repair. Explore some of 2022's hot MS research topics.

Many trials for people with MS are testing repurposed drugs. This means finding a new use for existing medicines. But how can one drug treat multiple conditions? And if a drug has been tested before, why would we test it again?

Recently, a therapy which reprograms your immune cells was used to treat a small group of people with the condition lupus. MS is similar to lupus because they both involve the immune system attacking the body. So could the findings help people with MS?